The Use of Chemotherapy in the Management of Neuroendocrine Tumors
- 1 December 1993
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 22 (4) , 941-952
- https://doi.org/10.1016/s0889-8529(18)30142-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumoursEuropean Journal Of Cancer, 1992
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- Metastatic carcinoid and islet cell tumours of the pancreas: A phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatinEuropean Journal of Cancer and Clinical Oncology, 1991
- Treatment of Malignant Midgut Carcinoid Tumours with A Long-Acting Somatostatin Analogue OctreotideActa Oncologica, 1991
- Neuroendrocine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patientsJournal of Internal Medicine, 1990
- Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumorsCancer, 1990
- Treatment of Malignant Metastatic Midgut Carcinoid Tumours with Recombinant Human o2b Interferon with or without Prior Hepatic Artery EmbolizationScandinavian Journal of Gastroenterology, 1989
- Cytotoxic Treatment in Patients with Malignant Carcinoid Tumors: Response to streptozocin—alone or in combination with 5-FUActa Oncologica, 1987
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1980